Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy ; volume:8 ; number:1 ; day:6 ; month:3 ; year:2018 ; pages:1-2 ; date:12.2018
Scientific reports ; 8, Heft 1 (6.3.2018), 1-2, 12.2018
- Creator
-
Jokerst, Jesse V.
- Contributor
-
Cauwenberghs, Nicholas
Kuznetsova, Tatiana
Haddad, Francois
Sweeney, Timothy
Hou, Jiayi
Rosenberg-Hasson, Yael
Zhao, Eric
Schutt, Robert
Bolli, Roberto
Traverse, Jay H.
Pepine, Carl J.
Henry, Timothy D.
Schulman, Ivonne H.
Moyé, Lem
Taylor, Doris A.
Yang, Phillip C.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-22121-2
- URN
-
urn:nbn:de:1111-201805112493
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.04.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jokerst, Jesse V.
- Cauwenberghs, Nicholas
- Kuznetsova, Tatiana
- Haddad, Francois
- Sweeney, Timothy
- Hou, Jiayi
- Rosenberg-Hasson, Yael
- Zhao, Eric
- Schutt, Robert
- Bolli, Roberto
- Traverse, Jay H.
- Pepine, Carl J.
- Henry, Timothy D.
- Schulman, Ivonne H.
- Moyé, Lem
- Taylor, Doris A.
- Yang, Phillip C.
- SpringerLink (Online service)
Other Objects (12)
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Screening circulating proteins to identify biomarkers of fetal macrosomia
Tumor biomarkers that identify molecular subtypes and best responders to chemotherapy in patients with PDAC
Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients
Patient-specific heart simulation can identify non-responders to cardiac resynchronization therapy
Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome
Biomarkers in cancer/Circulating tumour markers
Analysis of merged whole blood transcriptomic datasets to identify circulating molecular biomarkers of feed efficiency in growing pigs
Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
Genome-wide characterization of circulating metabolic biomarkers
PW01-018 – Circulating endothelial biomarkers in FMF
Biological age estimation using circulating blood biomarkers
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Screening circulating proteins to identify biomarkers of fetal macrosomia
Tumor biomarkers that identify molecular subtypes and best responders to chemotherapy in patients with PDAC
Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients
Patient-specific heart simulation can identify non-responders to cardiac resynchronization therapy
Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome
Biomarkers in cancer/Circulating tumour markers
Analysis of merged whole blood transcriptomic datasets to identify circulating molecular biomarkers of feed efficiency in growing pigs
Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
Genome-wide characterization of circulating metabolic biomarkers
PW01-018 – Circulating endothelial biomarkers in FMF
Biological age estimation using circulating blood biomarkers
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Screening circulating proteins to identify biomarkers of fetal macrosomia
Tumor biomarkers that identify molecular subtypes and best responders to chemotherapy in patients with PDAC
Metabolic profiles identify circulating biomarkers associated with heart failure in young single ventricle patients
Patient-specific heart simulation can identify non-responders to cardiac resynchronization therapy
Circulating lymphocyte subsets as promising biomarkers to identify septic patients at higher risk of unfavorable outcome
Biomarkers in cancer/Circulating tumour markers
Analysis of merged whole blood transcriptomic datasets to identify circulating molecular biomarkers of feed efficiency in growing pigs
Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
Genome-wide characterization of circulating metabolic biomarkers
PW01-018 – Circulating endothelial biomarkers in FMF